Serdexmethylphenidate Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Serdexmethylphenidate is part of the composition of Azstarys, which consists of a
prodrug/drug co-formulation ofserdexmethylphenidate and
dexmethylphenidate in a 70:30 molar ratio. Azstarys is approved by the USFDA for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older.
Serdexmethylphenidate consists of pharmacologically active dimethylphenidate attached to the nicotinoyl-L-serine portion via a carboxymethylene linker.
Serdexmethylphenidate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
